Downregulation of c-Myc expression confers sensitivity to CHK1 inhibitors in hematologic malignancies.
Jiang KL, Tong LX, Wang T, Wang HL, Hu XB, Xu GY, Jin TT, Kan WJ, Xu L, Li JN, Zhang KX, Song N, Liu JY, Zhang MM, Wu WB, Xiang YQ, Gao AH, Hu YZ, Zhou YB, Liu T, Yang JM, Li J.
Jiang KL, et al.
Acta Pharmacol Sin. 2022 Jan;43(1):220-228. doi: 10.1038/s41401-021-00652-1. Epub 2021 Mar 29.
Acta Pharmacol Sin. 2022.
PMID: 33782542
Free PMC article.